Navigation Links
YM BioSciences reports second quarter 2010 operational and financial results
Date:2/8/2010

to the two new clinical trials for non-small cell lung cancer patients ineligible for curative treatment who are being treated palliatively (NSCLC) and patients with brain metastases from non-small cell lung cancer, as well as the ongoing pediatric glioma trial.

Costs associated with development activities for AeroLEF(R) decreased by $0.7 million for the three month period ended December 31, 2009 compared to the same period in the prior year. For the six month period ended December 31, 2009 costs decreased by $0.8 million compared to the same period in the prior year.

Net loss for the second quarter of fiscal 2010 was $3.4 million ($0.06 per share) compared to $3.2 million ($0.06 per share) for the same period last year. Net loss for the first six months of fiscal 2010 was $6.9 million ($0.12 per share) similar to the same period in the prior year.

As at December 31, 2009 the Company had cash and cash equivalents and short-term deposits totaling $35.9 million and payables and accrued liabilities totaling $1.5 million compared to $42.1 million and $0.9 million respectively at June 30, 2009.

As at December 31, 2009 the Company had 55,946,835 common shares outstanding, of which 2,380,953 common shares are held in escrow to be released contingent upon the completion of certain milestones.

About YM BioSciences

YM BioSciences Inc. is a life sciences product development company. Together with
'/>"/>

SOURCE YM BioSciences Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. Neurocrine Biosciences Announces the Appointment of William H. Rastetter to Its Board of Directors
2. Sangamo BioSciences Reports Fourth Quarter and Full Year 2009 Financial Results
3. Sangamo BioSciences Announces Presentation at BIO CEO & Investor Conference
4. Cellectricon Files Patent Infringement Suit Against Fluxion Biosciences
5. YM BioSciences announces FDA clearance for two ongoing Phase II nimotuzumab trials into USA
6. YM BioSciences announces result of Cytopia shareholder vote
7. Profectus Biosciences to Present at Key Investor Conference in January 2010
8. David L. Macdonald Appointed CEO of GeneLink BioSciences, Inc.
9. YM BioSciences Inc. and Therapure Biopharma Inc. Announce Contract
10. Nu-Tek BioSciences, LLC. Launches Animal-Free, Non-GM Soy Peptone
11. Cardio3 BioSciences Completes Patient Enrolment in First Stage of Pivotal Trial of C-Cure(R) in Heart Failure
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... Calif. , Dec. 22, 2014  ( www.competitivehealth.com ... CoPatient, an online medical bill review and advocacy service, ... in the FREE WellCard Savings discount health services marketplace. ... bill that was more than they expected to pay. ... reduce health care costs, WellCard Savings is pleased to ...
(Date:12/22/2014)... 22, 2014 Fertility Associates of Memphis ... Bank USA , a network of more than 20 ... partnership, patients have fast access to a national pool ... IVF . Fertility Associates of Memphis is the only ... treatment option. , Dr. William Kutteh , director ...
(Date:12/19/2014)... BioPlus Specialty Pharmacy (BioPlus), ... promotion of Nick Maroulis, Pharm.D. to the newly created ... , In this position, Dr. Maroulis will continue to ... directors of our multi-site pharmacies as the company expands. ... during that time he has served in many different ...
(Date:12/19/2014)... REDWOOD CITY, Calif. , Dec. 19, 2014 ... , USA) announced today that they have been ... Technologies 1,2 is a privately held company that ... processing of next generation sequencing (NGS) data for the ... into the Roche Sequencing Unit, and will continue to ...
Breaking Biology Technology:WellCard Savings Announces CoPatient Medical Bill Review Service for Members 2Fertility Associates of Memphis Announces Partnership with Donor Egg Bank USA 2Fertility Associates of Memphis Announces Partnership with Donor Egg Bank USA 3BioPlus Specialty Pharmacy Promotes Dr. Nick Maroulis to Vice President of Specialty Pharmacy Services 2Bina Technologies is acquired by Roche. 2Bina Technologies is acquired by Roche. 3
... 23, 2011 Genesis Biopharma, Inc. (OTC.BB:GNBP), a biotechnology ... California Governor, Gray Davis, has joined the company as ... committed to the improvement of healthcare and advancement of ... California became a leader in stem cell research as ...
... Syngenta announced today that it plans to construct a ... research campus in Research Triangle Park, North Carolina. The ... June 2011, will focus on discovering and developing new ... the world.   "This investment demonstrates ...
... May 20, 2011 Dendreon Corporation (Nasdaq: DNDN ) ... ThinkEquity Annual Healthcare Conference in New York City, NY ... Annual Global Healthcare Conference in Rancho Palos Verdes, CA on June ... presentations will be webcast live and available for replay from Dendreon,s ...
Cached Biology Technology:Governor Gray Davis Joins Genesis Biopharma as Chairman of Corporate Advisory Board 2Syngenta to Invest in New U.S. Genetics Research Facility 2
(Date:12/11/2014)... 2014  Data Sciences International (DSI), the global ... new series of digital telemetry implants to meet ... series, part of the PhysioTel™ Digital platform, was ... physiologic data when incorporating functional endpoints into repeat-dose ... toxicology studies has evolved from short ECG strips ...
(Date:12/10/2014)... --Research and Markets ( http://www.researchandmarkets.com/research/xclcvw/biometrics_market ) ... Market in Japan 2014-2018" report to their ... The integration of biometrics and smart ... upgradation of the driver,s license is one of ... the aforementioned projects, biometrics is being used as ...
(Date:12/3/2014)... , Dec. 2, 2014   Marvin Test ... innovative test solutions for military, aerospace, and manufacturing ... of its successful TS-900 PXI semiconductor test ... features of high-end systems to customers at a ... compared to traditional ATE. "Our ...
Breaking Biology News(10 mins):New telemetry implants expected to change how large animal toxicology studies are conducted 2Biometrics Market in Japan 2014-2018: Key Vendors are DDS, Fujitsu, Hitachi and NEC 2Marvin Test Solutions Brings New Capabilities to PXI-Based Semiconductor Test with TS-960 2Marvin Test Solutions Brings New Capabilities to PXI-Based Semiconductor Test with TS-960 3
... the new research results of the VTT Technical Research Centre ... of high-quality biofuels for the price of less than one ... the transfer of more than half the energy of wood ... for the construction of a commercial-scale production plant in Europe. ...
... Amsterdam, July 3, 2013 - Elsevier, a world-leading provider ... today announced the publication of a recent retrospective study ... better understand treatment considerations and outcomes for same-sex male ... The number of same-sex male couples and single ...
... has produced a potential new antibiotic which could help ... The potential new antibiotic targets a bacterial enzyme critical ... inhibitor which binds to the enzyme (called biotin protein ... of the bacteria. "Existing antibiotics target the bacterial ...
Cached Biology News:Gasification method turns forest residues to biofuel with less than a euro per liter 2Reproductive BioMedicine Online publishes study on assisted reproduction 2Novel chemistry for new class of antibiotic 2
... Series Multimode Detectors provide unmatched value ... application and automation needs. Capable of ... on the same instrument, the DTX ... or can be integrated seamlessly with ...
... Solution is available in a ready-to-use ... reagent for dewaxing paraffin-embedded tissue sections ... hybridization, or other analytical methods. The ... of dipping the slides in a ...
... The MJ Mini thermal cycler is a compact ... x 0.2 ml tubes, 12 x 0.5 ml ... heated lid uses a thumbwheel to adjust height ... oil-free cycling. Peltier heat pumps provide excellent thermal ...
MiniCycler thermal cycler with Hot Bonnet heated lid, holds 25x0.2ml tubes...
Biology Products: